ETON - Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript

2025-08-08 15:27:44 ET

Eton Pharmaceuticals, Inc. (ETON)

Q2 2025 Earnings Conference Call

August 07, 2025, 04:30 PM ET

Company Participants

David C. Krempa - Chief Business Officer

James R. Gruber - CFO, Treasurer & Secretary

Sean E. Brynjelsen - President, CEO & Director

Conference Call Participants

Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division

Madison Britt Wynne El-Saadi - B. Riley Securities, Inc., Research Division

Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Thank you for standing by. My name is Alex, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Eton Pharmaceuticals Q2 2025 Earnings Call. [Operator Instructions] Thank you.

I would now like to turn the call over to Mr. David Krempa. Please go ahead.

David C. Krempa

Thank you, operator. Good afternoon, everyone, and welcome to Eton's Second Quarter 2025 Conference Call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, etonpharma.com....

For further details see: